Andrew Lo, Director at BridgeBio Pharma, Inc. (BBIO), sold 100,000 shares at $38.50 ($3.9M) on 2025-05-02, disclosed to the SEC on 2025-05-06.
Open-market sale of $3.9M BBIO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| UROV | BUY | 2019-06-19 | $303K | — | Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |
| UROV | BUY | 2019-06-11 | $292K | — | Filing → |